India BIRAC Biotechnology Ignition Grant

Captured cycle: This page is retained for historical guidance. Confirm whether the program has reopened before planning an application.

India BIRAC Biotechnology Ignition Grant (BIG)

If you are building a biotech or life-science product in India and you are still in the idea-to-prototype phase, BIG can be one of the strongest funding options because it is explicitly designed for exactly that stage. It is not a grant for “done” companies, and it is not a research fellowship. It is a grant-in-aid to convert high-potential ideas into proof of concept, while giving teams access to incubation, mentoring, and technical support.

The program is run by the Biotechnology Industry Research Assistance Council (BIRAC), India’s biotech innovation agency under the DBT ecosystem. BIRAC positions BIG as its flagship early-stage scheme for translational biotech, and the official page states it supports projects with commercialization potential through up to ₹50 lakh over up to 18 months.

At-a-glance summary

What this program is (and is not)

What BIG is

BIG is a pre-commercialization bridge program. It gives founders in biotech-related domains enough runway and structured handholding to validate a concept that is too early for Series A and too technical for generic startup support. You are expected to bring a concrete problem, a plausible technical path, and a realistic budget plan, not just an academic idea.

The program gives grant support along with ecosystem access. A key practical difference from pure grant programs is that BIRAC pairs funding with a dedicated BIG Partner (one of multiple BIG incubator partners across India). Those partners usually provide technical review support, mentor mapping, milestone planning help, and often facilitate compliance preparation.

What BIG is not

• It is not for basic science research with no commercial exit.
• It is not a passive grant where funds are handed out regardless of progress.
• It is not a generic startup “idea fund” for projects that are already at pilot/scale stage.
• It is not a one-shot submission with guaranteed review at your preferred date; calls are cyclical and strict.

Why this matters for normal founders

People who come to BIG often overestimate what seed money means. The grant is small enough that it can feel symbolic, but large enough to force you to define a credible plan in detail.

In practice, this has two effects:

1. You must prove that your idea can move from “interesting” to “testable and repeatable.”
2. You must design execution around measurable milestones, because disbursements are milestone-linked in current program notes.

That discipline can be useful even if you fail this cycle, because it leaves you with an investor-ready package and a cleaner technical development plan.

What BIG usually offers

Based on official BIRAC pages and program documents:

• Funding support up to ₹50 lakh as grant-in-aid.
• Milestone-oriented release of funds (with installment details published in call guidance).
• Mentorship support through BIG Partners.
• A project monitoring structure that includes technical and financial review.
• Access to support around IP, legal, contracts, regulatory thinking, and investor connections.
• Exposure to an ecosystem of incubators and sector experts.
• A formal reporting relationship; grant accounting is expected to be auditable and disciplined.

Who should apply

This opportunity is worth your time if your startup or innovation team matches most of the below:

• You have an idea in healthcare, diagnostics, medical devices, drugs/formulations, agriculture, biosimilars, bioinformatics, or related life-science domain.
• Your work is at or near proof-of-concept stage.
• The solution is not purely exploratory; there is a clear commercialization path.
• You can demonstrate technical progress (even if partial) before applying.
• You are willing to engage in close monitoring, reporting, and mentor interactions.

Most suitable applicants

• Early-stage founders from academia who have moved beyond concept toward implementation.
• Teams with a realistic niche domain plan: e.g., a focused diagnostics workflow, a specific industrial biotech pilot, or a treatment-related delivery concept with defined validation tasks.
• Incubatee-led teams that can show facility access and credible time commitment.

Most likely to be rejected early

• Teams with only literature-based promises and no execution strategy.
• Teams expecting the grant to fund long-term operations without measurable milestones.
• Teams that ignore eligibility constraints (especially legal and incorporation rules).
• Teams relying only on intention without letters/documents showing facilities, resources, or advisors.

Eligibility: what to check before spending a week on this

BIG has several rules that look bureaucratic but are important to pass before technical review starts.

Applicant type rules

Official scheme language distinguishes company/LLP and individual pathway details. As of the latest available guidance, the core rules include:

• Companies/LLPs should generally be recent entities (within about five years from call launch in current guidelines).
• Indian citizenship/control rules apply: at least 51% beneficial ownership must be by eligible Indian entities/individuals.
• Ineligible categories include OCI/PIO applicants in the individual ownership context under the current legal definition.
• A company founder/owner applying under the individual route is generally treated as a company category applicant if applicable.

Operational readiness rules

For a company/LLP, BIRAC expects either:

• an in-house functional R&D facility sufficient for the project, or
• valid incubation arrangement with an approved infrastructure partner.

For individual applicants, incubation requirement and full-time engagement obligations are repeatedly emphasised. It is safer to assume the call-specific guidelines can add additional documentary proof requirements for both routes.

What is disqualifying in advance

• If the startup is already too mature for this stage.
• If there is active grant support for the same project from another agency with matching objectives.
• If eligibility declarations are inconsistent or unverifiable.
• If the project is basic research only.
• If the team structure violates the founder-shareholding and applicant-role expectations.

Practical implications

Before drafting, draft your own “eligibility declaration audit” with:

• entity registration date and documents,
• ownership pattern,
• promoter stakes and related-party checks,
• lab access evidence,
• incubator association evidence,
• and team role clarity (who is Project Leader).

That one pass alone saves most late-stage disqualifications.

Application process (official workflow, simplified)

BIRAC’s own process is multi-tiered and best treated as a funnel:

1. National call announcement: typically twice yearly; the call is announced and usually open for roughly 30–45 days.
2. Online submission: only through BIRAC portal.
3. BIG Partner screening: the selected BIG Partner for that call checks legal and technical fit first.
4. Expert review: screened applications go to technical reviewers and committee levels.
5. Presentation to TEP (Technical Evaluation Panel): shortlisted teams present their project.
6. Financial and technical due diligence: after recommendation, stricter checks and documentation.
7. Offer and agreement: accepted only within a defined acceptance window.
8. Project execution and monitoring: milestones, utilization certificates, and periodic review.

This is a serious pipeline, and most teams are filtered in step 1/2 due incomplete submissions or weak project definition.

Timeline and calendar reality

A recurring trap is treating BIG like a rolling application model.

• Calls are announced periodically and have specific deadlines.
• The portal stops accepting submissions at the published date/time.
• You cannot usually change your proposal after submission.
• “Submit one week before” is often not enough unless you have clean documentation.

Use a practical reverse timeline after call launch:

• Day 1–3: confirm exact documents accepted for this call and required format.
• Week 1–2: finalize scope, problem statement, PoC objective, and resource map.
• Week 3: draft full technical narrative + budget + implementation milestones.
• Week 4: map evidence (NOC/letters, advisor undertakings, facility proof).
• Week 5: pre-submit mock review against eligibility and evaluation criteria.
• Week 6: final submission with margin before final deadline.

If this seems too late, shorten your pilot objective before submitting. BIG favors realistic, focused projects over over-scoped ideas.

Required materials and what reviewers actually want to see

Prepare the following in a complete package:

• Proposal document: problem statement, technical approach, expected deliverables, milestones, and commercialization pathway.
• Budget plan: use realistic line items with cap awareness and linked justification for each expense.
• Proof of team readiness: CVs, roles, full-time commitment assumptions.
• Incubator evidence: letter of intent/acceptance or facility access proof.
• Scientific advisor commitment: if required, advisor undertaking and scope.
• Technical data: preliminary validation, pilot data, design assumptions, and clear limitations.
• Regulatory and ethics mapping: if relevant, a risk/compliance plan and sample pathways.
• Legal/IP status: existing ownership, licensing, and intended filing plan.
• Execution support map: supplier/manufacturer/assay access and fallback options.
• Future funding pathway: realistic next steps after BIG (follow-on support, private funding, strategic partnerships).

Reviewers are less interested in polished slide decks and more in whether your project can be executed within 18 months and ₹50 lakh with visible checkpoints.

Budget and spending approach

The scheme is capped at ₹50 lakh and milestone-based. Even where exact split details vary by call, practical budgeting usually includes:

• manpower/salaries
• consumables
• recurring operational costs
• outsourcing and testing
• incubation support-related expenses
• travel for validation and investor interactions
• IP/legal/regulatory costs
• contingency/reserve

Budget traps to avoid:

1. Spending heavily early without linking each expense to a milestone.
2. Ignoring implementation dependencies (facility time, sample access, assay lead times).
3. Reserving too much for non-core activities and leaving no cash for validation.
4. Treating compliance filings as optional.

A practical way: align each budget row to a measurable milestone and include “if X fails, then Y is cut.” That sounds administrative, but it is exactly how due diligence teams evaluate realism.

Milestone design for 18 months

A practical working structure:

• Months 0–3: feasibility validation, protocol finalization, regulatory pre-check.
• Months 4–9: early validation and prototype/assay stabilization.
• Months 10–15: repeatability checks, optimization, initial pilot deployment or partner validation.
• Months 16–18: finalize technical package, finalize market plan, closeout report and future funding dossier.

If your technical cycle has more than two major external dependencies (e.g., specialist facility access and field trial partner), use buffer milestones. This reduces panic when delays happen.

How to estimate if it is worth your time

Use this 5-point readiness score (0–10 each)

1. Commercial clarity: Is the customer/problem statement specific?
2. Technical readiness: Can you show current state and proposed next validation?
3. Execution readiness: Do you have team, lab, and mentor support?
4. Documentation readiness: Can you submit complete forms and evidence before deadline?
5. Stage fit: Is your project genuinely at PoC stage?

If your score is consistently below 4 in 2+ categories, re-scope before applying.

The rule of thumb

BIG is worth pursuing if:

• the science is specific enough to test within 18 months,
• the team can commit to operational reporting,
• and you can articulate at least one concrete customer validation path.

What this grant does to your planning discipline

Applicants often report the biggest gain from BIG is not the ₹50 lakh alone; it is process discipline:

• clear technical milestones,
• realistic budgeting,
• stronger mentor access,
• and a cleaner transition to private capital.

The grant requires auditable processes, which can be painful if your team is still casual with records. But this is often exactly what future investors appreciate.

Selection criteria that commonly separate winners from “good ideas”

From official guidance, evaluation usually checks:

• unmet need and value proposition,
• technical novelty and feasibility,
• team capability and adviser support,
• business perspective and commercialization potential,
• ability to identify and mitigate technical/regulatory risks.

In other words, teams need both a strong science base and a believable business logic. A great idea without commercial detail and a polished sales story without execution depth both fail.

Common mistakes to avoid

1. Assuming “biotech startup” alone is enough: scope matters. BIRAC emphasizes commercialization and PoC.
2. Ignoring the incubator proof: whether in-house lab or incubated arrangement, the infrastructure must be demonstrable.
3. Submitting weak evidence: no letters, no facility proof, no advisor commitments.
4. Underestimating due diligence: legal, technical, and financial checks come after review but before funding.
5. Treating the grant as one-time spend: if milestones are late or unachieved, disbursement pauses and project rhythm breaks.
6. Over-scoping: teams with five ambitious directions often lose. Choose one high-confidence trajectory.
7. Not planning reporting from day 1: utilization and progress reporting is part of execution, not a post-facto chore.
8. Assuming same rules every cycle: checks and document requirements can change by call.

Step-by-step preparation playbook

Step 1: Define fit

Write a one-paragraph statement: problem, current status, proof need, and one measurable success metric. If you cannot write it in one paragraph, the application scope is too broad.

Step 2: Validate eligibility

Prepare registration docs, ownership proof, promoter composition, and lab/incubator access proof before narrative writing.

Step 3: Build the technical package

Use a standard structure:

• objective,
• method,
• milestone chart,
• failure plan,
• alternative pathways.

Step 4: Tighten commercialization logic

Write one page on:

• target customer,
• where and how adoption happens,
• pricing logic,
• regulatory step required for your class of technology,
• pilot partner pathway.

Step 5: Budget defensibly

Every line item should map to one milestone. Add a “why needed now?” note.

Step 6: Internal pre-review

Have someone unfamiliar with the project review for coherence: can they tell what you are building in 60 seconds and where it will fail?

Step 7: Submit early and keep backups

Upload everything in one pass with a backup copy of all docs as per portal format.

Applicant readiness FAQ

Who can apply: individual or company?

Both may be eligible under scheme rules, but categories differ. In many calls, individual route conditions are stricter and often require incubator linkage and full-time engagement. Check the current call for category-specific wording.

Is a registered lab required before applying?

No single answer applies universally. In principle, companies need functional R&D infrastructure, either in-house or via incubation. Confirm how your chosen call defines adequate access and verification.

Is ₹50 lakh enough?

It is enough for PoC-stage work and de-risking, not for full commercialization. Think of BIG as a staged bridge, not full build-out finance.

Is mentor support guaranteed?

It is part of BIG’s partner-led model, but quality varies by team engagement and partner capacity. The more prepared your team, the more useful the mentorship becomes.

Can BIG funds be used for salaries?

Yes, salary-like costs appear in budget templates, but they must be tied to execution and approved structure.

Can individual founders from academia apply while staying employed?

There are explicit rules around founder commitment and employment/consulting status in many call documents. If your case is unusual, document clearly before submission.

What happens after selection?

You enter a milestone-linked execution process with reporting requirements, utilization documentation, and due diligence checkpoints.

What happens if you miss a milestone?

The application can be at risk of delayed disbursements and may affect continued funding. For this reason, milestone design should be conservative and achievable.

Official links and references

• Main program page: BIG program page
• Latest available guideline PDF: BIG 2025 guidance
• Earlier scheme text (historical reference): Revised BIG guidelines PDF

Next steps after reading this

If you have a project that genuinely needs this type of support, your next action should be:

1. Pull the latest call notice from the BIRAC page.
2. Build a one-page “fit check” against the points above.
3. Decide if your idea is truly at PoC stage and close enough to execute in 18 months.
4. Prepare documents in the checklist format before the portal opens.
5. Run a mentor review before submitting, not after.

If your project does not pass this filter, pause and wait for a cleaner call cycle rather than submit a rushed application. In this program, a rejected rushed application usually costs you more than waiting one cycle and reapplying with better evidence.